Vittorio Gentile Selected Research

Transglutaminases

1/2014	Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
1/2014	Possible physiopathological roles of the transglutaminase activity in the etiopathogenesis of human neurodegenerative diseases.
12/2013	Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
8/2013	Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
1/2013	Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
2/2011	Possible role of the transglutaminases in the pathogenesis of Alzheimer's disease and other neurodegenerative diseases.
11/2010	Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
3/2008	Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders.
1/2006	Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vittorio Gentile Research Topics

Disease

13	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 01/2002
10	Huntington Disease (Huntington's Disease) 01/2014 - 01/2002
9	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 04/2004
9	Paralysis (Palsy) 01/2014 - 04/2004
9	Parkinson Disease (Parkinson's Disease) 01/2014 - 04/2004
6	Celiac Disease (Celiac Sprue) 01/2014 - 01/2006
4	Pathologic Processes 01/2014 - 05/2010
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Neuroblastoma 01/2013
1	Nervous System Diseases (Neurological Disorders) 11/2012
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 10/2002

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2002
9	polyglutamineIBA 01/2014 - 01/2006
9	TransglutaminasesIBA 01/2014 - 01/2006
5	EnzymesIBA 08/2013 - 03/2008
3	Protein Glutamine gamma Glutamyltransferase 2IBA 08/2013 - 01/2006
2	Therapeutic UsesIBA 01/2013 - 02/2011
1	Protein Isoforms (Isoforms)IBA 11/2012
1	CystamineIBA 04/2004
1	Cysteamine (Mercaptamine)FDA Link 04/2004
1	AntioxidantsIBA 04/2004
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2002
1	Protein AggregatesIBA 01/2002